[HTML][HTML] An overall view of the most common experimental models for multiple sclerosis

S Dedoni, M Scherma, C Camoglio, C Siddi… - Neurobiology of …, 2023 - Elsevier
Multiple sclerosis (MS) is a complex chronic disease with an unknown etiology. It is
considered an inflammatory demyelinating and neurodegenerative disorder of the central …

An appraisal of emerging therapeutic targets for multiple sclerosis derived from current preclinical models

A Dixit, HS Savage, JM Greer - Expert Opinion on Therapeutic …, 2023 - Taylor & Francis
Introduction Multiple sclerosis (MS) is a chronic inflammatory, demyelinating, and
neurodegenerative condition affecting the central nervous system (CNS). Although …

[HTML][HTML] Role of Selenium in Pathogenesis and Treatment of the Autoimmune Diseases

E Rahmani, AM Fard, H Baghsheikhi, Z Hosseini… - Kindle, 2022 - preferpub.org
In vitro investigations have revealed that consumption of selenium can considerably
decrease the expression of IFN-g in Th1 cells. A low plasma selenium content has been …

Dynamics of reactive astrocytes fosters tissue regeneration after cuprizone‐induced demyelination

LJ Schröder, F Mulenge, A Pavlou, T Skripuletz… - Glia, 2023 - Wiley Online Library
Demyelination in the central nervous system (CNS) is a hallmark of many
neurodegenerative diseases such as multiple sclerosis (MS) and others. Here, we studied …

[PDF][PDF] Fasudil-modified macrophages reduce inflammation and regulate the immune response in experimental autoimmune encephalomyelitis

C Liu, S Guo, R Liu, M Guo, Q Wang… - Neural Regeneration …, 2023 - journals.lww.com
Multiple sclerosis is characterized by demyelination and neuronal loss caused by
inflammatory cell activation and infiltration into the central nervous system. Macrophage …

The Effects of NLY01, a Novel Glucagon-Like Peptide-1 Receptor Agonist, on Cuprizone-Induced Demyelination and Remyelination: Challenges and Future …

M Gharagozloo, D Galleguillos, L Jank, ES Sotirchos… - …, 2023 - Springer
Recent evidence suggests that the glucagon-like peptide-1 receptor (GLP-1R) agonists
have neuroprotective activities in the CNS in animal models of Parkinson's disease …

ApTOLL: A new therapeutic aptamer for cytoprotection and (re) myelination after multiple sclerosis

B Fernández‐Gómez, MA Marchena… - British Journal of …, 2024 - Wiley Online Library
Abstract Background and Purpose ApTOLL is an aptamer selected to antagonize toll‐like
receptor 4 (TLR4), a relevant actor for innate immunity involved in inflammatory responses in …

[HTML][HTML] A preclinical mice model of multiple sclerosis based on the toxin-induced double-site demyelination of callosal and cerebellar fibers

S Vejar, IS Pizarro, R Pulgar-Sepúlveda… - Biological Research, 2024 - Springer
Background Multiple sclerosis (MS) is an irreversible progressive CNS pathology
characterized by the loss of myelin (ie demyelination). The lack of myelin is followed by a …

Discovery of BIO-8169─ A Highly Potent, Selective, and Brain-Penetrant IRAK4 Inhibitor for the Treatment of Neuroinflammation

M Pfaffenbach, PN Bolduc, Z Xin, F Gao… - Journal of Medicinal …, 2024 - ACS Publications
Interleukin receptor associated kinase 4 (IRAK4) plays an important role in innate immune
signaling through Toll-like and interleukin-1 receptors and represents an attractive target for …

[HTML][HTML] Transient gestational hypothyroxinemia accelerates and enhances ulcerative colitis-like disorder in the male offspring

JC Rivera, MC Opazo… - Frontiers in …, 2024 - frontiersin.org
Introduction Gestational hypothyroxinemia (HTX) is a condition that occurs frequently at the
beginning of pregnancy, and it correlates with cognitive impairment, autism, and attentional …